Background: Individuals with diabetes may be particularly susceptible to mo
tility-related upper gastrointestinal (UGI) symptoms such as abdominal pain
or discomfort, bloating, early satiety, nausea, and vomiting. We estimated
the prevalence of UGI symptoms in a population-based sample of individuals
with diabetes and determined whether cases and population controls differe
d in prevalence of UGI symptoms and in symptom features. Methods: Individua
ls with diabetes (n = 483) and matched controls (n = 422) were recruited fr
om a prior U.S. national health survey for a telephone interview on UGI sym
ptoms, To confirm self-reported diabetes status, cases provided information
on clinical management measures. Subjects were asked about UGI symptoms in
the month before interview. Affirmative responses to initial questions tri
ggered detailed questions about symptom frequency. timing, duration, and se
verity. Differences between casts and controls were evaluated. Results: Cas
es not only had a significantly (P < 0.05) higher overall prevalence of one
ol more UGI symptoms in the past month (50%) than controls (38%). but they
also reported a significantly greater number of UGI symptoms than controls
. Almost 10% of cases reported three or more UGI symptoms in the past month
compared with 2% of control,. Our study also identified UGI symptom featur
es that were more relevant to cases and showed that one UGI symptom, heartb
urn, co-occurred significantly more often with UGI symptoms in cases than i
n controls. Conclusions: Upper GI symptoms are common in individuals with d
iabetes and more prevalent th;ln in controls. The symptoms are non-specific
and may reflect disruptions in motility or perception.